Pharmafile Logo

KOL Strategy

- PMLiVE

GSK gets OK in US for diabetes drug albiglutide

Once-weekly Tanzeum will compete against Victoza and Byetta after FDA approval

- PMLiVE

Boehringer plans to open trial data back to 1998

Will partner with Sanofi, GSK, Roche, Novartis and ViiV Healthcare on online platform

- PMLiVE

Merck gets US green light for allergy immunotherapy

Expected to provide a significant boost to company's partner Alk-Abello

Bristol-Myers Squibb (BMS) building

BMS files fixed-dose HIV combination in US

Combines Reyataz with Gilead Sciences' cobicistat

European Commission launches mHealth consultation

May lead to policy action by 2015

- PMLiVE

England’s clinical commissioning landscape

Who are the real masters in the new NHS?

- PMLiVE

HRW to expand into the US

Will open east coast office in May

- PMLiVE

Hall & Partners boosts senior health team

Appoints Jeanette Hodgson and promotes Marie Bennett

- PMLiVE

Oral hepatitis C regimens tackle advanced liver disease

 New data released at the International Liver Congress by AbbVie, Merck & Co and Gilead

- PMLiVE

GSK under investigation in Poland for ‘camouflaged bribes’

A regional manager and 11 doctors have been charged, according to a BBC report

- PMLiVE

Google Glass enters Parkinson’s trials

The smart glasses' potential will be evaluated as a patient assistant aid

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links